Product Images Buprenorphine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 26 images provide visual information about the product associated with Buprenorphine NDC 3215-1525 by Aveva Drug Delivery Systems Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

fig1 - fig1 slc 0054

This text provides a description of a drug delivery system with layers including a backing layer, overlapping adhesive film, separating layer, drug/polymer adhesive matrix, and a peakoff release liner. Each layer plays a specific role in delivering the drug effectively and efficiently.*

fig2 - fig2 slc 0054

This text provides data on the concentration of Buprenorphine Transdermal System (TDS) at 10 mcg/hour administered every 7 days for a total of 3 doses, with a sample size of 36. The concentration level is measured in picograms per milliliter (pg/mL) over a span of 26 days. The graph shows the change in concentration over time for the Buprenorphine TDS.*

fig3 - fig3 slc 0054

This is a measurement table showing the percent of reduction or improvement in pain for patients taking either a placebo or Buprenorphine TOS 10/20. The table indicates the results in increments from 0% to 100%.*

fig4 - fig4 slc 0054

This text provides information on Buprenorphine TDS 5 and Buprenorphine TDS 20, along with the percentage of patients improved and the percent of reduction/improvement in pain. The data is structured in a tabulated format, showing the different percentages of improvement and reduction in pain.*

image description - figa slc 0054

image description - figb slc 0054

image description - figc slc 0054

image description - figd slc 0054

image description - fige slc 0054

This appears to be a description of a figure labeled as "Figure E" with a foil backing, patch, and a foil handle. This suggests the presence of a product or material that involves a foil-based construction with specific features like a patch and handle.*

image description - figf slc 0054

image description - figg slc 0054

image description - figh slc 0054

image description - figi slc 0054

image description - figj slc 0054

image description - figk slc 0054

image description - figl slc 0054

image description - figm slc 0054

image description - fign slc 0054

image description - figo slc 0054

Carton-7.5mcg - image002

Carton-10mcg - image003

Carton-5mcg - image01

Carton-15mcg - image04

Carton-20mcg - image05

Description not available.*

structure - structure slc 0054

image description - table1 slc 0054

This text provides information on the recommended starting doses for Buprenorphine Transdermal System based on the previous opioid analgesic daily dose in oral morphine equivalent. The starting doses are 5 mcg/hour for a daily dose of <30 mg and 10 mcg/hour for a daily dose of 30-80 mg.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents